Lexington, MA, – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the publication of research supporting the Company’s flagship diagnostic test, T2Candida® , in Science Translational Medicine. The research highlights T2Candida as a breakthrough approach to rapid and sensitive identification of species-specific Candida, a sepsis-causing fungus, directly from whole blood […]
GLASGOW, Scotland, — Life Technologies Corporation (NASDAQ: LIFE) today announces that it is a lead commercial partner along with Aridhia, a bio-medical informatics company, in the Stratified Medicine Scotland Innovation Centre (SMS-IC). The Ion Proton ™ sequencing platform will be the primary tool to drive discovery and genetic analysis as SMS-IC aspires to be a […]
Seoul, South Korea, and Cambridge, Mass., –Seegene and Selventa today announced that they have entered into a strategic collaboration to develop novel molecular diagnostics in underserved diagnostic markets including autoimmune, cancer and infectious diseases. The synergistic combination of Selventa’s Systems Diagnostics (SysDx™) multi-omic analytics platform and Seegene’s TOCE™ and DPO™ multiplex PCR technology will result […]
Franklin Lakes, NJ – BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved the second drug to be offered in the recently launched BD Simplist™ line of ready-to-administer prefilled generic injectables. The second BD […]
Biomedical informatics company Aridhia today announced that it is a lead commercial partner alongside Life Technologies Corporation, a global biotechnology tools company, in the Stratified Medicine Scotland Innovation Centre (SMS-IC). The SMS-IC is a unique collaboration bringing together expertise from within Scottish industry, academia and the NHS to drive forward a new age of stratified […]
Baltimore, Maryland and Liege, Belgium – BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), and Diagenode SA, an international biotech company based in Belgium, announced today the availability of the CE-marked Diagenode Enteric Viral Panel primers and probes kit that is used with the BD MAX™ RNA extraction kit […]
SAN DIEGO & WUHAN, China — Illumina, Inc. (NASDAQ: ILMN) and Kindstar Global (Kindstar) today announced they are entering into a strategic collaboration whereby Kindstar will validate and implement molecular assays in their laboratories, leveraging Illumina’s TruSightTM content sets, Infinium® Dx CytoSNP-12 assay and NuPCRTM reagents. The collaboration will enable Kindstar to expand its esoteric […]
ANTA FE SPRINGS, Calif.– Applied BioCode today announced it has appointed Michael Aye, Ph.D. as its Vice President of Molecular Products. Dr. Aye will build and lead the assay development program for Applied BioCode and act as scientific liaison between Applied BioCode and the scientific community in the field of multiplexed molecular diagnostics. “We are […]
Granada and Madrid, Spain and Madison, WI, U.S., – Integromics®, a market leader in IT solutions for life sciences in the field of genomics and proteomics, today announces that it has entered into a partnership with the Celgene Institute for Translational Research Europe (CITRE) and the Centre of Studies and Technical Research (CEIT), for the […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) announced today that it is partnering with Ridom GmbH (Munster, Germany) to make SeqSphere+ whole genome bacterial typing software available for Ion Torrent users. This software enables any lab to perform fast, affordable, and automated high-resolution bacterial typing on the Ion Personal Genome Machine® (PGM™) sequencer. Up […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
